3D Models

Growth drivers 

Advancements in 3D cell culture technology;

Urgent need for better drug discovery methods.

Increase in the inclination towards personalized and regenerative medicines

Estimate of Market Size Growth

Main benefits 

Better evaluation, in an early stage, which drugs are effective compared to 2D cell line models

Faster development and less expensive compared to patient-derived xenograft (PDX) models.

Generation of patient-derived tumor organoids/spheroids, produced from a surgically removed tumor tissue.

Organoid / spheroid assay services.